Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique

Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia

(2011) Giuseppe Todeschini et al.   AMERICAN JOURNAL OF HEMATOLOGY

Prognostic significance of acute renal injury in acute tumor lysis syndrome

(2010) Michael Darmon et al.   LEUKEMIA & LYMPHOMA

A comparison of three methods to estimate baseline creatinine for RIFLE classification

(2010) J. Zavada et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Organ crosstalk: the role of the kidney

(2009) Xiang Li et al.   Current Opinion in Critical Care

Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model

(2008) P. Montesinos et al.   HAEMATOLOGICA

Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review

(2008) Bertrand Coiffier et al.   JOURNAL OF CLINICAL ONCOLOGY

Single-dose rasburicase for tumour lysis syndrome in adults: weight-based approach

(2008) M. Campara et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Intensity of Renal Support in Critically Ill Patients with Acute Kidney Injury

(2008)   NEW ENGLAND JOURNAL OF MEDICINE